CompaniesAculeus Therapeutics
Aculeus Therapeutics logo

Aculeus Therapeutics

active
Parkville, Australia
Founded 2020
Website
About

Immune-modulatory small molecules

Areas of Focus

Categories

Small Molecule PharmaceuticalAustralia
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

13

By Phase

PHASE2: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
Today
NCT05061017
Hover over trial bars to see details

Recent Trials

NCT05061017Collaborator
Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC)
PHASE2Completed
13 participants
Started: Dec 9, 2021 · Completed: Mar 18, 2024
Locations (1)
Headquarters
Parkville, Australia
Map

Loading map...